This course addresses legal/regulatory risk, and compliance considerations for healthcare professionals with respect to psychedelic therapy. The goal of the course is to familiarize participants with (i) possible lessons to be drawn from the past 25 years of expanding allowance for therapeutic use of medical marijuana for psychedelic therapy; (ii) questions as to how the expansion of use of psychedelic therapy may differ from the medical marijuana “journey” to date; (iii) addressing ongoing limitations in federal law, including the Controlled Substances Act and Food, Drug, and Cosmetic Act; and (iv) articulating risk mitigation and sound compliance practices for physicians and other health professionals in psychedelic therapy. Participants will obtain a framework for understanding regulatory compliance and risk management in prescribing or recommending psychedelics, documenting the clinical relationship, and avoiding risks in the clinical use of psychedelics
Healthcare Law and Psychedelic Therapy
Introduction to ERISA Benefits Claims and Litigation
One of the foremost Experts on ERISA Claims and Litigation, Paul M. Sullivan, Jr. takes you through a five-step plan he created in the filing of an ERISA Claim. …
Drafting and Negotiating Commercial Agreements: An Introduction
A practical ‘nuts and bolts’ approach to reviewing, drafting/revising, and negotiating commercial contracts as well as a process for approaching commercial agreements as well as some drafting/negotiating guidelines.